Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition used for preventing and treating urarthritis and hyperuricemia

A technology for gouty arthritis and hyperuricemia, applied in the field of medicine, can solve the problems of large side effects and easy recurrence, and achieve the effect of reducing blood uric acid content, no toxic side effects, and relieving pain

Inactive Publication Date: 2012-01-11
张珂
View PDF1 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although these three types of western medicine can achieve obvious effects temporarily, they usually have serious side effects, which are common in gastrointestinal dysfunction, liver and kidney dysfunction, skin rash, dermatitis, etc., especially after stopping the medicine, it is easy to relapse, so it is not the fundamental solution.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition used for preventing and treating urarthritis and hyperuricemia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] The selected prescription is 7 parts of Qumai, 8 parts of Clematis, and 10 parts of Gentiana chinensis. Take the above medicinals and decoct them with water, twice a day, and the course of treatment is 12 days. After several years of clinical treatment of 153 patients, 15 of them received one treatment. Among them, 132 cases were treated twice, 6 cases were treated three times, 122 cases were cured, the recovery rate was 79.7%, 21 cases were markedly effective, the markedly effective rate was 13.5%, and the total effective rate was 93.46%.

Embodiment 2

[0049] The selected prescriptions were 15 parts of Qumai, 6 parts of Clematis, and 6 parts of Gentiana chinensis, and decocted them with water, twice a day, for 12 days. After several years of clinical treatment of 78 patients, 4 of them received one treatment. Among the 74 cases treated twice, 67 cases were cured, the recovery rate was 85.9%, 8 cases were markedly effective, the markedly effective rate was 10.2%, and the total effective rate was 96.1%.

Embodiment 3

[0051]The selected prescriptions are 15 parts of Qumai, 8 parts of Clematis, 5 parts of Gentiana, 3 parts of Guizhi, and 12 parts of Salvia miltiorrhiza, decocted with water, twice a day, and the course of treatment is 12 days. After several years, 200 clinical cases of patients Carry out treatment, wherein carry out 9 examples of treating once, carry out 165 examples of treating twice, carry out 28 examples of treating three times, recover from illness 174 examples, recovery rate 87.0%, markedly effective 22 examples, markedly effective rate 11%, total effective rate 98%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical composition used for preventing and treating urarthritis and hyperuricemia. The pharmaceutical composition comprises the following components in parts by weight: 7-15 parts of fringed pink, 5-10 parts of radix clematidis and 5-13 parts of large-leaved gentian. The invention provides the pharmaceutical composition used for preventing and treating urarthritis and hyperuricemia, and the pharmaceutical composition can lower blood uric acid content of gout patients, alleviate pain, prevent uric acid from rising and restore and improve the metabolism function of the patients and has no toxic and side effects.

Description

technical field [0001] The invention belongs to the field of medicine and relates to a pharmaceutical composition for preventing and treating gouty arthritis and hyperuricemia. Background technique [0002] Gout is a long-term purine metabolic disorder, a group of diseases caused by elevated blood uric acid and tissue damage. The clinical features are: hyperuricemia, recurrent episodes of acute arthritis, tophi formation, chronic arthritis and joint deformities, and uric acid stones and gouty renal parenchymal lesions in the later stages of the disease course. [0003] The cause of gout: All foods contain different amounts of purine, and the purine content of different food units even varies by a thousand times. After people eat high-purine food for a long time, it is easy to cause poor metabolism, excessive uric acid production, decreased uric acid excretion or even excretion disorder, resulting in increased uric acid in the blood, and gout often occurs when the blood uric...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/716A61K9/20A61K9/16A61K9/48A61K9/00A61P19/06A61P19/02
Inventor 张珂
Owner 张珂
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products